Raphael Pharmaceutical INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OQB
Raphael Pharmaceutical Inc. reports a successful RA product launch and provisional patent filing, but faces significant operating losses and going concern doubts.
OQB
Raphael Pharmaceuticals Inc. reports its annual results on Form 10-K, highlighting continued operating losses and the necessity for substantial additional funding to advance its pharmaceutical drug product candidates.
OQB
Raphael Pharmaceutical Inc. extends a board member's appointment and provides an update on its pre-clinical development of cannabinoid-based therapies for rheumatoid arthritis and COVID-19 related inflammation in its annual report.